RecruitingNCT05329935

Congenital Athymia Patient Registry

Studying 22q11.2 deletion syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sumitomo Pharma Switzerland GmbH
Intervention: Cultured Thymus Tissue(biological)
Enrollment: 75 enrolled
Eligibility: 0-21 years · All sexes
Timeline: 2022 – 2026

Study locations (1)

Duke University School of Medicine, Durham, North Carolina, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05329935 on ClinicalTrials.gov

Other trials for 22q11.2 deletion syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT05664412
Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
Stephan Eliez
RECRUITINGNCT05924347
Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development
UMC Utrecht
RECRUITINGNANCT04639388
Understanding of Psychotic Disorders in Children With 22q11.2DS
Hôpital le Vinatier
RECRUITINGNCT00556530
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Albert Einstein College of Medicine

See all trials for 22q11.2 deletion syndrome →

← Back to all trials